- Report
- March 2025
- 250 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 194 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 137 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- August 2024
- 141 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Clinical Trials
- May 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- February 2025
- 186 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2025
- 250 Pages
Global
From €4771EUR$4,999USD£3,997GBP
- Report
- December 2024
Global, Europe, United States, ... Global, Europe, United States, Japan
From €17656EUR$18,500USD£14,793GBP
- Report
- February 2025
Japan, United States, ... Japan, United States, Europe, Global
From €3579EUR$3,750USD£2,999GBP
- Report
- December 2024
Canada, Mexico, North America Canada, Mexico, North America
From €9067EUR$9,500USD£7,597GBP
- Report
- December 2024
United States
From €2386EUR$2,500USD£1,999GBP
- Report
- February 2025
Middle East
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2025
Mexico, North America, ... Mexico, North America, Canada
From €2338EUR$2,450USD£1,959GBP
- Report
- February 2025
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From €2720EUR$2,850USD£2,279GBP
- Report
- February 2025
United States
From €1384EUR$1,450USD£1,159GBP
- Report
- September 2019
- 30 Pages
China
From €2100EUR$2,200USD£1,759GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- October 2023
- 178 Pages
Global
From €4295EUR$4,500USD£3,598GBP

Prothrombin is a hematological drug used to treat and prevent blood clotting disorders. It is a form of vitamin K-dependent clotting factor, which is produced in the liver and is essential for normal blood clotting. Prothrombin is used to treat and prevent conditions such as deep vein thrombosis, pulmonary embolism, and stroke. It is also used to prevent bleeding in patients with liver disease or who are taking anticoagulants. Prothrombin is available in both injectable and oral forms.
The prothrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Sanofi, Bayer, and Merck. These companies offer a range of products, including injectable and oral forms of prothrombin, as well as generic versions. Show Less Read more